Advances in Gene Therapy in India Thalassemia Market
Regional analysis reveals that India’s metropolitan cities lead in adoption of advanced thalassemia treatments, while smaller towns are gradually improving access through government initiatives.
The India Thalassemia Market was valued at USD 310 million in 2023 and is projected to reach USD 485 million by 2032 at a CAGR of 5.6%. Urban hospitals, specialized clinics, and diagnostic centers drive growth.
Programs aimed at increasing awareness, early diagnosis, and accessibility in tier-2 and tier-3 cities are expected to expand the patient base.
The India Thalassemia Market Regional Share indicates high growth potential in under-served regions as infrastructure improves.
1 View